drugset / Trial / NCT04996134
Domperidone Expanded Access Treatment Program
Summary
To allow the use of domperidone by patients with gastrointestinal disorders who have failed standard therapy.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Domperidone | Unknown | 10 mg | Oral |
| Subject | Domperidone | Unknown | 30 mg | Oral |